A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B

NCT07190742 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B Virus

Interventions

DRUG: TVAX-008
DRUG: Placebo

Sponsor

Grand Theravac Life Sciences (Nanjing) Co., Ltd.